Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Puma Biotechnology
PBYI
|
+$276M |
| 2 |
Home Depot
HD
|
+$240M |
| 3 |
TE Connectivity
TEL
|
+$232M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$191M |
| 5 |
SHPG
Shire pic
SHPG
|
+$181M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$279M |
| 2 |
Meta Platforms (Facebook)
META
|
+$271M |
| 3 |
NVIDIA
NVDA
|
+$233M |
| 4 |
Cadence Design Systems
CDNS
|
+$222M |
| 5 |
CSX Corp
CSX
|
+$209M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.46% |
| 2 | Healthcare | 15.52% |
| 3 | Financials | 13.32% |
| 4 | Industrials | 12.73% |
| 5 | Consumer Discretionary | 11.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEE
76
DELISTED
Sealed Air
SEE
| $526M | 0.32% |
10,667,501
+96,339
| +0.9% | +$4.43M |
|
77
Costco
COST
$415B
| $519M | 0.32% |
2,789,630
-163,538
| -6% | -$28.2M |
|
78
Philip Morris
PM
$301B
| $512M | 0.31% |
4,844,464
+1,515,628
| +46% | +$161M |
|
79
Air Products & Chemicals
APD
$66.3B
| $509M | 0.31% |
3,100,195
+325,952
| +12% | +$51.9M |
|
80
Merck
MRK
$324B
| $503M | 0.31% |
9,360,870
+2,333,439
| +33% | +$129M |
|
81
UnitedHealth
UNH
$382B
| $500M | 0.3% |
2,266,862
-77,290
| -3% | -$16.4M |
|
82
DexCom
DXCM
$27.6B
| $497M | 0.3% |
34,660,096
-619,204
| -2% | -$8.05M |
|
83
Amdocs
DOX
$5.53B
| $494M | 0.3% |
7,545,657
+57,139
| +0.8% | +$3.71M |
|
84
Biogen
BIIB
$29.9B
| $487M | 0.3% |
1,528,386
+88,235
| +6% | +$28.3M |
|
|
DNKN
85
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $475M | 0.29% |
7,364,500
-1,262,460
| -15% | -$73.6M |
|
86
Cimpress
CMPR
$2.37B
| $474M | 0.29% |
3,957,706
-122,126
| -3% | -$14M |
|
|
NATI
87
DELISTED
National Instruments Corp
NATI
| $470M | 0.29% |
11,301,230
+497,011
| +5% | +$21.7M |
|
88
Cooper Companies
COO
$13.7B
| $465M | 0.28% |
8,532,352
-208,720
| -2% | -$12.2M |
|
89
Revvity
RVTY
$12.3B
| $465M | 0.28% |
6,354,160
+192,671
| +3% | +$13.8M |
|
90
Verisk Analytics
VRSK
$26.4B
| $461M | 0.28% |
4,801,917
-222,295
| -4% | -$20.1M |
|
|
SHPG
91
DELISTED
Shire pic
SHPG
| $459M | 0.28% |
2,961,392
+1,220,419
| +70% | +$181M |
|
92
Goldman Sachs
GS
$313B
| $457M | 0.28% |
1,793,441
-71,245
| -4% | -$17.5M |
|
93
Cisco
CSCO
$450B
| $455M | 0.28% |
11,871,791
+769,083
| +7% | +$27.5M |
|
94
Nice
NICE
$5.29B
| $455M | 0.28% |
4,947,660
-58,960
| -1% | -$5.02M |
|
95
Walt Disney
DIS
$165B
| $454M | 0.28% |
4,219,589
-931,578
| -18% | -$96M |
|
96
Neurocrine Biosciences
NBIX
$17.7B
| $448M | 0.27% |
5,772,111
+264,348
| +5% | +$18M |
|
97
Teleflex
TFX
$5.85B
| $441M | 0.27% |
1,770,356
-41,118
| -2% | -$10.3M |
|
|
XLNX
98
DELISTED
Xilinx Inc
XLNX
| $440M | 0.27% |
6,519,746
-328,373
| -5% | -$23.3M |
|
99
Hershey
HSY
$35.4B
| $439M | 0.27% |
3,864,960
-503,902
| -12% | -$55.4M |
|
100
3M
MMM
$89B
| $437M | 0.27% |
2,221,648
+81,953
| +4% | +$15.8M |
|
Similar funds
Janus Henderson Group's Q4 2017 Portfolio in Review
As of Q4 2017, Janus Henderson Group held 1,379 positions worth $165B, up 5.4% from $156B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Janus Henderson Group's Q4 2017 filing shows 95 new, 535 increased, 621 reduced and 76 closed positions. Its largest new stake was Invitation Homes: 5,558,350 shares worth $131M. The largest sale was Lowe's Companies, an estimated $279M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q4 2017 buy was Invitation Homes: 5,558,350 shares worth $131M.
- Janus Henderson Group added most to Puma Biotechnology in Q4 2017, an estimated $276M increase.
- Janus Henderson Group's biggest Q4 2017 reduction was Lowe's Companies, cutting an estimated $279M.
- Janus Henderson Group fully exited CR Bard Inc. in Q4 2017, selling an estimated $124M.
- Janus Henderson Group's ten largest holdings make up 14% of its $165B portfolio in Q4 2017.
- Janus Henderson Group opened 95 new positions and closed 76 in Q4 2017.
- Janus Henderson Group's portfolio value rose 5.4% quarter-over-quarter to $165B.
Based on Janus Henderson Group's 13F filing for Q4 2017, filed 9 Feb 2018.